A Biotech ETF Gets Its Groove Back
After struggling through one of its worst annual performances in several years in 2016, the SPDR S&P Biotech ETF , the third-largest biotechnology exchange traded fund, is surging to start 2017.
from Biotech News
After struggling through one of its worst annual performances in several years in 2016, the SPDR S&P Biotech ETF , the third-largest biotechnology exchange traded fund, is surging to start 2017.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments